Marché nord-américain du traitement des troubles de la ménopause – Tendances et prévisions du secteur jusqu’en 2030

Analyse et taille du marché du traitement des troubles de la ménopause en Amérique du Nord

Ces dernières années, le marché devrait connaître une croissance rapide au cours de la période de prévision 2023-2030. La ménopause encourage énormément les sociétés pharmaceutiques du monde entier à créer des médicaments efficaces pour la traiter et les problèmes qui y sont associés. Environ 85 % des femmes ménopausées ont connu un symptôme de la ménopause au cours de leur vie entière, et l'incidence totale des seuls symptômes vasomoteurs est estimée à environ 40 à 50 millions de femmes aux États-Unis. Les problèmes de ménopause sont de plus en plus répandus dans le monde entier, et de nombreuses organisations de soins de santé soutiennent le développement et l'utilisation de médicaments capables de les traiter efficacement.

Data Bridge Market Research analyse le taux de croissance du marché du traitement des troubles de la ménopause au cours de la période de prévision 2023-2030. Le TCAC attendu du marché du traitement des troubles de la ménopause a tendance à être d'environ 7,6 % au cours de la période de prévision mentionnée. La valeur du marché est de 5 957,4 millions USD en 2022 et elle atteindrait 10 704,2 millions USD d'ici 2030. En plus des informations sur le marché telles que la valeur du marché, le taux de croissance, les segments de marché, la couverture géographique, les acteurs du marché et le scénario du marché, le rapport de marché organisé par l'équipe de Data Bridge Market Research comprend également une analyse approfondie des experts, une épidémiologie des patients, une analyse du pipeline, une analyse des prix et un cadre réglementaire.

Portée et segmentation du marché du traitement des troubles de la ménopause en Amérique du Nord

Market Definition

Menopause is a natural biological process which occurs due to the reduction of reproductive hormones. This marks the end of the menstrual cycle. It usually occurs in the late 40s or 50s. The menopause symptoms occur differently for every women. It has been noticed that the estrogen levels decline throughout menopause. Many women witness symptoms such as night sweats, vaginal dryness, hot flashes while some face abnormal menstrual cycles, difficulty sleeping, mood swings, and others.

North America Menopausal Disorder Treatment Market Dynamics

Drivers

• Increasing Demand of Herbal Treatments

With each passing decade, women are inclining more towards herbal supplements for their menopause treatment which is one of the market's most significant latest developments. As a result, numerous companies are responding to the market need by manufacturing latest products which contain menopause-relieving components. For instance, soy isoflavones and  black cohosh are the two natural remedies that work well for menopause. Thus, this new concept is increasing the market growth rapidly.

• Increased Drug Development Processes

An increase in the number of menopausal drugs in the drug development pipeline of several major manufacturers is one of the huge opportunities for the growth of the market. It includes specific and innovative drugs that primarily focus on decreasing side effects and providing improved efficacy. For instance, The first and only body-identical hormone replacement therapy (HRT) for oestrogen insufficiency symptoms in postmenopausal women with an intact uterus and at least a year post their last period, Bijuva, also called as Bijuve in the U.K., which includes estradiol and progesterone in a single daily oral capsule. Thus, this boosts the market growth.

 Opportunities

• Major Impact of Trending Lifestyle and Stress

In recent years, it has become positively important to provide women with much effective therapy for menopause symptoms because of the rise in the occurrence of physical and mental health issues among women. Factors such as migraine, anxiety, irritability, formication, fatigue, hot flashes, mood swings, and insomnia led many companies to develop high-end therapies to improve these symptoms. Huge growth in the menopause therapy industry is being aided by widespread investments in extended R&D initiatives to launch novel medications. This factor is helping the market growth in a great way.

• Increasing Demand of Oral Drugs

Oral drugs are one of the easiest, most durable, affordable, and most portable mode of administration. It has been observed that the rate of contamination is also very minimum. This makes this route of administration more beneficial. The oral mode of administration is found to be beneficial especially for the elderly population who suffers from this disorder frequently. Thus, this factor enhances the growth of the market.

Restraints/Challenges

• Growing Underlying Disparities Between Genders

Numerous companies providing multiple treatments for menopause have struggled considerably due to the existence of major gender-wise health disparities in many countries. Women in several countries with limited awareness and income see no gains in their health due to the lack of adequate healthcare infrastructure. This acts as a major restriction for the market.  

• Side Effects of Hormone Therapy

According to the FDA, numerous complications associated with hormone therapy carry various hazards, including the possibility of heart problems, stroke, blood clots, and breast cancer. Thus, it hampers the market growth.   

This menopausal disorder treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the menopausal disorder treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

North America Menopausal disorder Treatment Market

The menopausal disorder treatment market is segmented on the basis of stages, type, menopause symptoms, dosage form, route of administration, end-user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Stages

• Menopause
• Postmenopause
• Perimenopause

Type

• Hormonal Therapy
• Non-Hormonal Therapy

Menopause Symptoms

• Vasomotor Symptoms
• Atrophic Vaginitis
• Osteoporosis
• Joint Pain
• Weight Gain
• Dyspareunia
• Depression
• Others

Dosage Form

• Tablet
• Cream

• Gels
• Rings/Insert
• Patch/Film
• Injection Shot
• Spray
• Others

Route of Administration

• Oral
• Vaginal
• Transdermal
• Parenteral

End User

• Hospital/Clinical Laboratories
• Physician Offices
• Reference Laboratories
• Others

Distribution Channel

• Direct Tender
• Retail Sales
• Other

North America Menopausal Disorder Treatment Market Regional Analysis/Insights

The menopausal disorder treatment market is analyzed and market size insights and trends are provided by stages, type, menopause symptoms, dosage form, route of administration, end-user and distribution channel as referenced above.

The major countries covered in the menopausal disorder treatment market report are U.K., Germany, France, Spain, Italy, Netherlands, Switzerland, Russia, Turkey, Belgium.

Germany is leading the menopausal disorder treatment market due to the growing demand of many effective treatments such as hormone replacement therapy. Also, the country witnessed advanced medical environment that has resulted in the world's lowest cancer mortality rates, a life expectancy for people over 80 years that is actually more compared to other regions, and minimized heart attack and stroke death rates than those in similar countries. Thus, all these factors led to the market growth in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and North America Menopausal Disorder Treatment Market Share Analysis

The menopausal disorder treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to menopausal disorder treatment market.

Les principaux acteurs opérant sur le marché du traitement des troubles de la ménopause comprennent :

• F. Hoffmann-La Roche SA (Suisse)
• Mylan NV (États-Unis)
• Teva Pharmaceutical Industries Ltd. (Israël)
• Sanofi (France), Pfizer Inc. (États-Unis)
• GSK plc (Royaume-Uni)
• Novartis SA (Suisse)
• AstraZeneca (Royaume-Uni)
• Johnson & Johnson Private Limited (États-Unis)
• Merck & Co., Inc. (États-Unis)
• Eli Lilly and Company (États-Unis)
• Abbott (États-Unis)
• Novo Nordisk A/S (Danemark)
• Abbvie, Inc (États-Unis)
• Dr. Reddy's Laboratories Ltd. (Inde)
• TherapeuticsMD, Inc. (États-Unis)
• Ipsen Pharma (France)
• Besins Healthcare (Belgique)
• Mithra Pharmaceuticals (Belgique)
• Aché Laboratórios Farmacêuticos SA (Brésil)
• SEBELA PHARMACEUTICALS (ÉTATS-UNIS)
• Fervent Pharmaceuticals Inc. (États-Unis)
• KaNDy Therapeutics (Royaume-Uni)
• Duchesnay USA (États-Unis) 

SKU-56618